Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark A. Boyd
Moving Away From Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE) - Agents That Concern Prescribers and Patients: A Feasibility Study and Call for a Trial
PLoS ONE
Multidisciplinary
Related publications
Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naive Adults With Hiv-1 Infection in the United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Efavirenz, Tenofovir and Emtricitabine Combined With First Line Tuberculosis Treatment in TB–HIV-coinfected Tanzania Patients: A Pharmacokinetic and Safety Study
Antiviral Therapy
Infectious Diseases
Pharmacology
Prescribers’ Knowledge, Attitudes and Perceptions About Blood Culturing Practices for Adult Hospitalized Patients: A Call for Action
Infection Control and Hospital Epidemiology
Epidemiology
Infectious Diseases
Microbiology
96-Week Results of Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Plus Efavirenz, in Antiretroviral-Naive, HIV-1-infected Adults: ASSERT Study
Antiviral Therapy
Infectious Diseases
Pharmacology
Comparison of Bone and Renal Effects in HIV-infected Adults Switching to Abacavir or Tenofovir Based Therapy in a Randomized Trial
PLoS ONE
Multidisciplinary
Effect of a Fixed-Dose Combination of Emtricitabine, Tenofovir and Efavirenz on Adherence and Treatment Acceptability (ADONE Study)
Journal of the International AIDS Society
Environmental
Public Health
Infectious Diseases
Occupational Health
Abacavir–Lamivudine Versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
New England Journal of Medicine
Medicine
ADePT (Algorithm for Decision-Making After Pilot and Feasibility Trials): A Decision Aid for Progression From Feasibility Study to Main Trial
Trials
Medicine
Pharmacology
